Cargando…

In Vivo Emergence of HIV-1 Highly Sensitive to Neutralizing Antibodies

BACKGROUND: The rapid and continual viral escape from neutralizing antibodies is well documented in HIV-1 infection. Here we report in vivo emergence of viruses with heightened sensitivity to neutralizing antibodies, sometimes paralleling the development of neutralization escape. METHODOLOGY/PRINCIP...

Descripción completa

Detalles Bibliográficos
Autores principales:	Aasa-Chapman, Marlén M. I., Cheney, Kelly M., Hué, Stéphane, Forsman, Anna, O'Farrell, Stephen, Pellegrino, Pierre, Williams, Ian, McKnight, Áine
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2011
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3161086/ https://www.ncbi.nlm.nih.gov/pubmed/21887353 http://dx.doi.org/10.1371/journal.pone.0023961

Ejemplares similares

Modulation of HIV-1 macrophage-tropism among R5 envelopes occurs before detection of neutralizing antibodies
por: Richards, Kathryn H, et al.
Publicado: (2010)

Extensive complement-dependent enhancement of HIV-1 by autologous non-neutralising antibodies at early stages of infection
por: Willey, Suzanne, et al.
Publicado: (2011)

Interferon-Alpha Mediates Restriction of Human Immunodeficiency Virus Type-1 Replication in Primary Human Macrophages at an Early Stage of Replication
por: Cheney, Kelly M., et al.
Publicado: (2010)

Llama Antibody Fragments Recognizing Various Epitopes of the CD4bs Neutralize a Broad Range of HIV-1 Subtypes A, B and C
por: Strokappe, Nika, et al.
Publicado: (2012)

Generation of a Family-specific Phage Library of Llama Single Chain Antibody Fragments That Neutralize HIV-1
por: Koh, Willie W. L., et al.
Publicado: (2010)

Mapping the immune response to the outer domain of a human immunodeficiency virus-1 clade C gp120
por: Chen, Hongying, et al.
Publicado: (2008)

Anti-infective activity of apolipoprotein domain derived peptides in vitro: identification of novel antimicrobial peptides related to apolipoprotein B with anti-HIV activity
por: Kelly, Bridie A, et al.
Publicado: (2010)

The ins and outs of HIV restriction
por: McKnight, Áine
Publicado: (2013)

Protease inhibitors effectively block cell-to-cell spread of HIV-1 between T cells
por: Titanji, Boghuma Kabisen, et al.
Publicado: (2013)

Expression of particulate-form of Japanese encephalitis virus envelope protein in a stably transfected Drosophila cell line
por: Zhang, Fuquan, et al.
Publicado: (2007)

P01-04. Investigation of the sensitivity of acute-phase HIV-1 isolates to type I interferons
por: Dibben, O, et al.
Publicado: (2009)

A gp41 MPER-specific llama VHH requires a hydrophobic CDR3 determinant for neutralization but not for antigen recognition
por: Weissenhorn, W, et al.
Publicado: (2012)

Human antibodies neutralizing diphtheria toxin in vitro and in vivo
por: Wenzel, Esther Veronika, et al.
Publicado: (2020)

Antiviral neutralizing antibodies: from in vitro to in vivo activity
por: Burton, Dennis R.
Publicado: (2023)

A whole genome screen for HIV restriction factors
por: Liu, Li, et al.
Publicado: (2011)

Relative resistance of HIV-1 founder viruses to control by interferon-alpha
por: Fenton-May, Angharad E, et al.
Publicado: (2013)

In vitro and in vivo protective efficacies of antibodies that neutralize the RNA N-glycosidase activity of Shiga toxin 2
por: Jeong, Kwang-il, et al.
Publicado: (2010)

Refined identification of neutralization-resistant CRF02_AG viruses and their sensitivity to anti-MPER neutralizing antibodies
por: Jacob, RA, et al.
Publicado: (2012)

A gp41 MPER-specific Llama VHH Requires a Hydrophobic CDR3 for Neutralization but not for Antigen Recognition
por: Lutje Hulsik, David, et al.
Publicado: (2013)

A novel envelope mediated post entry restriction of murine leukaemia virus in human cells is Ref1/TRIM5α independent
por: Oliveira, Nidia MM, et al.
Publicado: (2010)

Clinical testing for neutralizing antibodies to interferon-β in multiple sclerosis
por: Creeke, Paul I., et al.
Publicado: (2013)

Reversibility in dynamics and group theory
por: O'Farrell, A G, et al.
Publicado: (2014)

Hypothalamic PKA regulates leptin sensitivity and adiposity
por: Yang, Linghai, et al.
Publicado: (2015)

Beyond Chemistry: Tailoring Stiffness and Microarchitecture to Engineer Highly Sensitive Biphasic Elastomeric Piezoresistive Sensors
por: Solazzo, Matteo, et al.
Publicado: (2022)

Fc-Effector-Independent in vivo Activity of a Potent Influenza B Neuraminidase Broadly Neutralizing Antibody
por: Khalil, Ahmed M., et al.
Publicado: (2023)

Novel restriction factor RNA-associated early-stage anti-viral factor (REAF) inhibits human and simian immunodeficiency viruses
por: Marno, Kelly, et al.
Publicado: (2013)

Enteric Fever
por: O'Farrell, T.
Publicado: (1872)

Lack of protection in vivo with neutralizing monoclonal antibodies to transmissible gastroenteritis virus
por: Wesley, R.D., et al.
Publicado: (1988)

Novel restriction factor RNA-associated early-stage anti-viral factor (REAF) inhibits human and simian immunodeficiency viruses
por: Marno, Kelly M, et al.
Publicado: (2014)

Maturation of West Nile Virus Modulates Sensitivity to Antibody-Mediated Neutralization
por: Nelson, Steevenson, et al.
Publicado: (2008)

Potent and broad neutralization of HIV-1 by a llama antibody elicited by immunization
por: McCoy, Laura E., et al.
Publicado: (2012)

In vitro and in vivo functions of SARS-CoV-2 infection-enhancing and neutralizing antibodies
por: Li, Dapeng, et al.
Publicado: (2021)

Analysis of Memory B Cell Responses and Isolation of Novel Monoclonal Antibodies with Neutralizing Breadth from HIV-1-Infected Individuals
por: Corti, Davide, et al.
Publicado: (2010)

Enteric Fever
por: O'Farrell, Thomas
Publicado: (1874)

Indian Fevers
por: O'Farrell, Thomas
Publicado: (1874)

Evolution in Lateral Flow–Based Immunoassay Systems
por: O’Farrell, Brendan
Publicado: (2008)

Human PAF1 inhibition of HIV-1
por: Alonso, Ana Guerrero, et al.
Publicado: (2013)

Cooperativity Enables Non-neutralizing Antibodies to Neutralize Ebolavirus
por: Howell, Katie A., et al.
Publicado: (2017)

Discordant neutralizing antibody and T cell responses in asymptomatic and mild SARS-CoV-2 infection
por: Reynolds, Catherine J., et al.
Publicado: (2020)

Human Immunodeficiency Virus Type-1 (HIV-1) Continues to Evolve in Presence of Broadly Neutralizing Antibodies More than Ten Years after Infection
por: Chaillon, Antoine, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_m5m5mi2c6v1l62maqarpls32qf